Related Experiment Video
Updated: May 31, 2026

13:42
Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation
Published on: September 19, 2017
Piezoelectric sensors in point-of-care testing.
1Military Faculty of Medicine, University of Defense, Hradec Kralove, Czech Republic.
Advances in Clinical Chemistry
|May 29, 2026
Summary
Piezoelectric (PE) biosensors and chemosensors offer sensitive, rapid diagnostics for point-of-care testing (POCT). Integrating PE transducers with recognition elements shows great potential for decentralized clinical applications.
Area of Science:
- Materials Science
- Biotechnology
- Sensor Technology
Background:
- Piezoelectric (PE) sensors are increasingly vital for point-of-care testing (POCT).
- PE biosensors and chemosensors integrate PE transducers with biological/synthetic recognition elements.
- These systems enable sensitive, rapid, and decentralized diagnostic capabilities.
Purpose of the Study:
- To provide a comprehensive overview of PE biosensors and chemosensors for POCT.
- To critically evaluate analytical performance metrics of selected PE sensor studies.
- To highlight the potential of PE platforms for clinical diagnostics.
Main Methods:
- Review and critical evaluation of existing literature on PE biosensors and chemosensors for POCT.
- Focus on integration of PE transducers (QCM, BAW, cantilevers) with recognition elements.
- Analysis of studies based on limit of detection, dynamic range, specificity, and stability.
Main Results:
- Nanomaterials and engineered PE compounds significantly enhance signal transduction and assay sensitivity.
- PE platforms demonstrate versatility in detecting diverse analytes, including disease and cancer biomarkers.
- Selected studies show promising analytical performance for PE-based POCT.
Conclusions:
- PE POCT systems are technologically mature and adaptable.
- These systems offer viable alternatives to conventional optical and electrochemical sensors.
- PE biosensors and chemosensors hold significant potential for widespread clinical deployment.

